Tausa, Cayetano L.

HRN: 28-69-57  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2026
CEFTRIAXONE 1G (VIAL)
03/15/2026
03/21/2026
IV
1g
BID
Fracture, Abrasions
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: